VBL Therapeutics
Industry
- Biotechnology
- Drug Discovery Technologies
- ADMET
- Gene Therapy, Cell Therapy
- Drug Discovery Technologies
- Pharmaceuticals
- Drug Delivery
Other Names/Subsidiaries
- Vascular Biogenics Ltd.
Latest on VBL Therapeutics
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Partners With Verve Again By Acqu
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Adaptimmune, TCR² Combine Forces, Incre
The NASDAQ Biotech Index is down by nearly 27% since the last peak, the IPO window is virtually shut, there is diminished appetite for secondary offerings, the situation has been made worse by the col
The ongoing reckoning among biopharmaceutical companies that are running out of cash and unable to raise new funds – either because of a lack of near-term upcoming milestones or missed milestones – is